Creating a new vaccine approach for treating oral melanoma in dogs.
Development of novel AAV vaccine strategy in a pre-clinical model of oral melanoma.
This study is testing a new vaccine for dogs with oral melanoma, a type of cancer, to see if it can help their immune system fight the disease better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10997318 on NIH RePORTER |
What this research studies
This research focuses on developing a novel vaccine strategy using adeno-associated virus (AAV) vectors to stimulate the immune system against oral melanoma, a type of cancer affecting dogs. The team aims to optimize these AAV vectors to effectively deliver cancer antigens, enhancing the body's immune response. By conducting preclinical studies in companion dogs, the research seeks to evaluate the safety and effectiveness of these vaccines, potentially leading to improved cancer treatments. The project also investigates the interactions between AAV vectors and the immune system to maximize therapeutic outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are dogs diagnosed with oral melanoma.
Not a fit: Dogs with other types of cancer or those not diagnosed with oral melanoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer immunotherapies for oral melanoma in dogs, improving survival rates and quality of life.
How similar studies have performed: Other research has shown promise in using AAV vectors for cancer immunotherapy, indicating potential for success in this novel approach.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Aslanidi, George V — University of Minnesota
- Study coordinator: Aslanidi, George V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.